Impossible to please everyone on here Moosie but I bet if it was compulsory to have to leave your name beside your comment you would hardly get a bad rep ever.
Printable View
Would of been nice of them to have released this after market to be honest instead of a scramble to read it this morning.
With the ASB depth problems this morning im not overly stoked.
Do not let it bother you Moosie. If people want to vent because they did not heed your warning and have now lost loads of $$$ just let them stew. A fool and his/her money is easily parted. Interesting that for a lot of people "investing" becomes emotional and that is in itself a warning sign that you are in the wrong game.
From whats been disclosed not much to go on yet so we don't really know what is in trade debtors
March 12 figure included Trade Debtors (From revenues) / accrued interest / BAS refund due and a GST refund due
So it can include many things
Need to wait to see the notes to the accounts next month to make any real analysis
Hahaha, I'm surprised they didn't lead with sales up from $15022 to $145000. Makes for a great percentage.
Hopefully the same percentage growth next year and possible its more.
Disc, holding(35k) and sleeping at night
Disappointed yes thought we might have had a better result. Extending loss to 10m receiving 500k that would probably not cover the wage bill, Talk of setting up Spain please get the US paying it's way first how much will set up costs be for Spain and wait at least 2 years for a return?
Cash burn last year 10m but that's OK let's have another capital raising. Hope the management is up to the task of running this company the scientists have done a fabulous job over the last 12 years time for the management to step up. Thinking of selling out and look at it again next year done very well, I will find it hard to go through another 6 months information vacuum. CS comment we have no debt they don't need it when they have loyal shareholders to tap on the shoulder.
Agree with Hancocks here, a pretty dismal result. I was expecting sales to be at least in the 3000-5000 mark for 10 months at this point when covering a quarter of the population. It does seem to indicate a much slower uptake from urologists (than I was expecting) who are going through their user program too, I am sure there would quite a number of them who have been involved in this and given, say 3-6 months of free evaluations, which I would expect then to move into sales if they see value in CxBladder. The low number of sales suggests to me that many of them are opting out. Given that PEB have not stated the number of Urologists in the user program, nor their progression through the user program, methinks they don't want to tell us this information (user program to sales conversion ratio). That would be a key metric for us shareholders to judge acceptance and therefore future potential profitability.
Think I might bail until they give us more information that has better news. Doesn't bother me much as I am still sitting on 100%+ profit but I feel for those who got in on the high side of $1.30.
Nevertheless, we are probably still onto a winner here as the science is sound, which their results indicate. It just might not be a winner in the states (hugely political medical environment) or may be a LOT slower than I was expecting. Expecting much more pain over the next few days regarding SP... three days of drops?
Part of Hancocks earlier post - The result is very poor for a $9Million spend in my opinion, I measured progress based on commentary and documentation from Pacific Edge and it did not measure up to me.
Accumulated losses are now $46m - you could have said a very poor result for a $46m spend over many years building up to this
Be a riot if they announce the Medicaid deal tomorrow eh
What would insurance coverage have on the effect of uptake?
Continued respect for your comments Hancocks. Many a holder with much less of a holding than yourself will try to put a spin on what is a pretty mediocre result, 145k in actual sales e.g (non interest/grants) at a cost of a cool 10m.
Anyone honest whether holders or not would admit that is at the very low end of expectations.
What I find interesting is the fact they were able to budget the loss within 130k, -9.379m actual, to -9.251m budget. As they comfortingly say, the loss was "within budgeted expectations".
Hey if these guys have such a good insight, and accurate budgeting, why can't they turn it into some forward guidance instead of just trotting the 100m in 5 years all the time? As for whether there was or wasn't any talk of positive cash flows this financial year, knowing how good their budgeting is, there must have been a misquote somewhere as it can't have come from them.